| Thu, Jul 9, 2009 | | | AnalystChoice.com Brings You the Best Complimentary Research Report on INFY, ANPI, SUSQ, ODFL, LSTR and CWTR Marketwire (Thu 8:21am)
| | Mon, Jul 6, 2009 | | | Angiotech Pharmaceuticals Earnings Call scheduled for Thu, Aug 6 CCBN (Mon, Jul 6)
| | | Angiotech Pharmaceuticals, Inc. announces conference call and webcast PR Newswire (Mon, Jul 6)
| | | Medical Device Trades: 7 Stocks Under 5 Bucks at Seeking Alpha (Mon, Jul 6)
| | Tue, Jun 16, 2009 | | | 5 Stocks Approaching Greatness at Motley Fool (Tue, Jun 16)
| | Tue, Jun 9, 2009 | | | 4-Star Stocks on the Upswing at Motley Fool (Tue, Jun 9)
| | | [$$] Headwaters Is Off, but Piedmont Is On at The Wall Street Journal Online (Tue, Jun 9)
| | Mon, Jun 8, 2009 | | | [$$] Biotech and China Still Have Aggressive Trading at RealMoney by TheStreet.com (Mon, Jun 8)
| | | Angiotech says FDA approves embolism filter AP (Mon, Jun 8)
| | | Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter PR Newswire (Mon, Jun 8)
| | | Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter CNW Group (Mon, Jun 8)
| | Wed, Jun 3, 2009 | | | ANGIOTECH PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an EDGAR Online (Wed, Jun 3)
| | | Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation PR Newswire (Wed, Jun 3)
| | Tue, Jun 2, 2009 | | | 10 Stocks to Shake the Market at Motley Fool (Tue, Jun 2)
| | Wed, May 27, 2009 | | | [video] Snacks Sell In Downturn at Forbes.com (Wed, May 27)
| | | 4-Star Stocks on the Upswing at Motley Fool (Wed, May 27)
| | | Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberté(R) Atom(TM) Stent system CNW Group (Wed, May 27)
| | | Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system PR Newswire (Wed, May 27)
| | Wed, May 20, 2009 | | | SYNTAX analysis finds treatment with TAXUS(R) Express(2)(R) Stent System more cost effective than bypass surgery in patients with complex coronary artery disease system PR Newswire (Wed, May 20)
| | | SYNTAX analysis finds treatment with TAXUS(R) Express(2)(R) Stent System more cost effective than bypass surgery in patients with complex coronary artery disease system CNW Group (Wed, May 20)
| Add ANPI News to My Yahoo!:

| |
|